|
1)
Frequency of the LRRK2 G2019S
mutation in Italian patients affected by Parkinson's disease.
Squillaro T, Cambi F, Ciacci G, Rossi S, Ulivelli M, Malandrini A,
Mencarelli MA, Mari F, Renieri A, Ariani F.
J Hum Genet.
2007;52(3):201-4.
2)
A case report: bone marrow
mesenchymal stem cells from a Rett syndrome patient are prone to
senescence and show a lower degree of apoptosis.
Squillaro T, Hayek G, Farina E, Cipollaro M, Renieri A, Galderisi U.
J Cell Biochem.
2008 Apr 15;103(6):1877-85.
3)
Histone deacetylase inhibitors
promote apoptosis and senescence in human mesenchymal stem cells.
Di Bernardo G, Squillaro T, Dell'Aversana C, Miceli M, Cipollaro M,
Cascino A, Altucci L, Galderisi U.
Stem Cells Dev.
2009 May;18(4):573-81.
4)
In vitro senescence of rat
mesenchymal stem cells is accompanied by downregulation of stemness-related
and DNA damage repair genes.
Galderisi U, Helmbold H, Squillaro T, Alessio N, Komm N, Khadang B,
Cipollaro M, Bohn W, Giordano A.
Stem Cells Dev.
2009 Sep;18(7):1033-42.
5)
Genes involved in regulation of
stem cell properties: studies on their expression in a small cohort of
neuroblastoma patients.
Melone MA, Giuliano M, Squillaro T, Alessio N, Casale F, Mattioli E,
Cipollaro M, Giordano A, Galderisi U.
Cancer Biol Ther.
2009 Jul;8(13):1300-6.
|